Report date: Nov 6,2024
Conflict count: 361874
Publisher: Mary Ann Liebert
Title count: 27
Conflict count: 246


==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405458
CauseID: 1430263666
JT: Human Gene Therapy
MD: Dunbar,9,17,2629,1998,Retroviral Transfer of the Glucocerebrosidase Gene into CD34+ Cells from Patients with Gaucher Disease: In Vivo Detection of Transduced Cells without Myeloablation
DOI: 10.1089/10430349850019463(Journal) (5405458-N)
DOI: 10.1089/hum.1998.9.17-2629(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405459
CauseID: 1430263666
JT: Human Gene Therapy
MD: Barnhart,9,17,2545,1998,Enhancer and Promoter Chimeras in Plasmids Designed for Intramuscular Injection: A Comparative In Vivo and In Vitro Study
DOI: 10.1089/10430349850019382(Journal) (5405459-N)
DOI: 10.1089/hum.1998.9.17-2545(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405456
CauseID: 1430263666
JT: Human Gene Therapy
MD: Mizuguchi,9,17,2577,1998,Efficient Construction of a Recombinant Adenovirus Vector by an Improved In Vitro Ligation Method
DOI: 10.1089/10430349850019418(Journal) (5405456-N)
DOI: 10.1089/hum.1998.9.17-2577(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405457
CauseID: 1430263666
JT: Human Gene Therapy
MD: Fan,9,17,2527,1998,Behavioral Recovery in 6-Hydroxydopamine-Lesioned Rats by Cotransduction of Striatum with Tyrosine Hydroxylase and Aromatic L-Amino Acid Decarboxylase Genes Using Two Separate Adeno-Associated Virus Vectors
DOI: 10.1089/10430349850019364(Journal) (5405457-N)
DOI: 10.1089/hum.1998.9.17-2527(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405446
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Furlan,9,17,2605,1998,Central Nervous System Delivery of Interleukin 4 by a Nonreplicative Herpes Simplex Type 1 Viral Vector Ameliorates Autoimmune Demyelination
DOI: 10.1089/10430349850019445(Journal) (5405446-N)
DOI: 10.1089/hum.1998.9.17-2605(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405447
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Puisieux,9,17,2481,1998,Canarypox Virus-Mediated Interleukin 12 Gene Transfer into Murine Mammary Adenocarcinoma Induces Tumor Suppression and Long-Term Antitumoral Immunity
DOI: 10.1089/10430349850019328(Journal) (5405447-N)
DOI: 10.1089/hum.1998.9.17-2481(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405450
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Vandenburgh,9,17,2555,1998,Attenuation of Skeletal Muscle Wasting with Recombinant Human Growth Hormone Secreted from a Tissue-Engineered Bioartificial Muscle
DOI: 10.1089/10430349850019391(Journal) (5405450-N)
DOI: 10.1089/hum.1998.9.17-2555(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405451
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Trobridge,9,17,2517,1998,Helper-Free Foamy Virus Vectors
DOI: 10.1089/10430349850019355(Journal) (5405451-N)
DOI: 10.1089/hum.1998.9.17-2517(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405448
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Byk,9,17,2493,1998,Lipofectamine and Related Cationic Lipids Strongly Improve Adenoviral Infection Efficiency of Primitive Human Hematopoietic Cells
DOI: 10.1089/10430349850019337(Journal) (5405448-N)
DOI: 10.1089/hum.1998.9.17-2493(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405449
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Fassati,9,17,2459,1998,Insertion of Two Independent Enhancers in the Long Terminal Repeat of a Self-Inactivating Vector Results in High-Titer Retroviral Vectors with Tissue-Specific Expression
DOI: 10.1089/10430349850019300(Journal) (5405449-N)
DOI: 10.1089/hum.1998.9.17-2459(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405454
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: ,9,17,2652,1998,Corrigendum
DOI: 10.1089/10430349850019490(Journal) (5405454-N)
DOI: 10.1089/hum.1998.9.17-2652(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405455
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Uckert,9,17,2619,1998,RNA Levels of Human Retrovirus Receptors Pit1 and Pit2 Do Not Correlate with Infectibility by Three Retroviral Vector Pseudotypes
DOI: 10.1089/10430349850019454(Journal) (5405455-N)
DOI: 10.1089/hum.1998.9.17-2619(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405452
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Hoganson,9,17,2565,1998,Targeted Delivery of DNA Encoding Cytotoxic Proteins through High-Affinity Fibroblast Growth Factor Receptors
DOI: 10.1089/10430349850019409(Journal) (5405452-N)
DOI: 10.1089/hum.1998.9.17-2565(Journal)
==========================================================

Created: 2018-08-08 16:47:06
ConfID: 5405453
CauseID: 1430263666
OtherID: 524696506
JT: Human Gene Therapy
MD: Yoshida,9,17,2503,1998,Generation of Fiber-Mutant Recombinant Adenoviruses for Gene Therapy of Malignant Glioma
DOI: 10.1089/10430349850019346(Journal) (5405453-N)
DOI: 10.1089/hum.1998.9.17-2503(Journal)